跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,483 条关于
“DMX-1001”
全部
4,483
临床试验
2,156
药物
1,331
机构
18
资讯
978
5个月前
DemeRx Receives FDA Clearance for Novel Neuroplastogen DMX-1001 to Treat Alcohol Use Disorder
2年前
Dimerix's First Patient Completes Phase 3 Trial and Enters DMX-200 Open Label Extension Study for Kidney Disease
去年
FDA Confirms Proteinuria as Primary Endpoint for Dimerix's DMX-200 Phase 3 FSGS Trial
11个月前
Dimerix's DMX-200 Receives Orphan Drug Designation in Japan for Rare Kidney Disease Treatment
9个月前
Dimerix Completes Recruitment for Phase 3 Trial of DMX-200 in Rare Kidney Disease FSGS
去年
Dimerix Licenses Phase 3 FSGS Drug DMX-200 to FUSO Pharma for ¥10.5 Billion
去年
Dimerix's Phase 3 Trial of DMX-200 for FSGS Completes Part 2 Recruitment, Interim Analysis Expected in August 2025
11个月前
Dimerix's DMX-200 Advances in Phase 3 FSGS Trial with Strong Safety Profile and FDA-Aligned Endpoint Data
2年前
iView Therapeutics Completes Enrollment in Phase 1/2 Trial of IVW-1001 for Dry Eye Disease
去年
Amicus Therapeutics Reports 15% Revenue Growth in Q1 2025, Expands Portfolio with DMX-200 Licensing Deal
第 1 页，共 98 页
上一页
下一页
